Incidence, therapy and prognosis of colorectal cancer in different age groups: A population-based cohort study of the Rostock Cancer Registry

Strahlentherapie und Onkologie

Volumn 180, Issue 8, 2004, Pages 478-487

  Fietkau, Rainer ^a   Zettl, Heike ^a   Klöcking, Sabine ^a   Kundt, Günther ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Chemotherapy; Colorectal cancer; Elderly patients; Radiochemotherapy; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; FEMALE; GERMANY; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RECTUM CANCER; STATISTICAL ANALYSIS;

EID: 4043182598     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1260-z     Document Type: Article

References (23)

1. Altmann U, Katz FR, Tafazzoli A, et al. GTDS - a tool for tumor registries to support shared patient care, Proc AMIA Annu Fall Symp 1996:512-6.
2. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a poputation-based cohort. J Clin Oncol 2003;21:1293-300.
3. Edna TH, Bjerkeset T. Colorectal cancer in patients over 80 years of age. Hepatogastroenterology 1998;45:2142-5.
4. Gatta G, Faivre J, Capocaccia R, et al. Survival of colorectal cancer patients in Europe during the period 1978-1989. Eur J Cancer 1998;14:2176-83.
5. Grothey A, Kellermann L, Schmoll HJ. Deficits in management of patients with colorectal carcinoma in Germany. Results of multicenter documentation of therapy algorithms. Med Klin 2002;97:270-7.
6. Iwashyna TJ, Lamont EB. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer. J Clin Oncol 2002;20:3992-8.
7. Köhne CH, Grothey A, Bokemeyer C, et al. Chemotherapy in elderly patients with colorectal cancer. Ann Oncol 2001;12:435-42.
8. Kremser C, Judmaier W, Hein P, et at. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 2003;179:641-9.
9. Lewis JH, Kilgore ML, Goldman DB, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003;21:1383-9.
10. Mahoney T, Kuo YH, Topilow A, et al. Why adjuvant chemotherapy is not offered to elderly patients. Arch Surg 2000;135:182-5.
11. Nagel G, Röhrig B, Hoyer H, et al. A population-based study on variations in the use of radiotherapy in breast cancer patients. Strahlenther Onkol 2002;178:589-96.
12. National Cancer Institute of Canada. Canadian cancer statistics 2001. National Cancer Institute of Canada: Toronto, 2001.
13. National Institutes of Health. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990;264:1444-50.
14. Neugut AI, Fleischauer T, Sundararajan V, et al. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. J Clin Oncol 2002;20:2643-50.
15. Popescu RA, Norman A, Ross PJ, et al. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older. J Clin Oncol 1999; 17:2412-8.
16. Rödel C, Hohenberger W, Sauer R. Adjuvante und neoadjuvante Therapie des Rektumkarzinoms. Aktueller Stand. Strahlenther Onkol 1998;174:497-504.
17. Rödel F, Hoffmann J, Grabenbauer GG, et al. High survivin expression is associated with reduced apoptosis in rectal cancer and may predict disease-free survival after preoperative radiotherapy and surgical resection. Strahlenther Onkol 2002;178:426-35.
18. Sargent OJ, Goldberg RM, Jacobson SO, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001;345:1091-7.
19. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001;93:850-7.
20. Schrag D, Gelfand SE, Bach PB, et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology and end results - Medicare. J Clin Oncol 2001;19:3712-8.
21. Sobin LH, Wittekind C, eds. TNM classification of malignant tumours, 5th edn. New York: Wiley-Liss, 1997.
22. Sundararajan V, Grann VR, Jacobson JS, et al. Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: a population-based study. Cancer J 2001;7:213-8.
23. Sundararajan V, Mitra N, Jacobson JS, et al. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Ann Intern Med 2002;136:349-57.